340B: Myths and Misconceptions

Recent investigations by news sources have commented on the legitimacy of the 340B program, trying to determine if the program is as beneficial to patients as it claims to be. The 340B program strives to stretch scarce federal resources to best provide comprehensive services and serve those with lesser access to health care.

340B: Myths and MisconceptionsRead More »

2022 Summer Coalition Recap

From August 1-3 in National Harbor, MD, covered entities, pharmacies, services providers, government agencies and drugmakers alike gathered to celebrate the 340B drug pricing program’s great successes since the last conference in 2019, and discuss continually evolving challenges.

2022 Summer Coalition RecapRead More »